Combination antiretroviral therapy is highly effective in HIV infection, leading to decreased incidences of AIDSdefining neoplasms. However, HIV patients still have a 10-fold increased risk of developing classical Hodgkin lymphoma compared with the general population. As Hodgkin-and Reed-Sternberg cells represent only a minority in the tumor infiltrate, the aim of the present study was to characterize the microenvironment of HIV-related classical Hodgkin lymphoma and compare it with classical Hodgkin lymphoma cases of immunocompetent individuals. The major morphologic differences were the presence of necrotic foci and the absence of epithelioid cell formation in HIV-related Hodgkin lymphoma. We observed a significantly decreased number of CD4 þ T-cells and a significantly increased number of CD163 þ macrophages in HIVrelated Hodgkin lymphoma. Cases exhibiting a 'sarcomatoid' pattern of the reactive infiltrate exhibited significantly greater numbers of macrophages, associating the 'sarcomatoid' pattern to the presence of spindle-shaped macrophages. Whereas, rosetting of CD4 þ T-cells around Hodgkin-and Reed-Sternberg cells was frequently observed in classical Hodgkin lymphoma in immunocompetent persons; rosetting in a subset of HIV-related Hodgkin lymphoma cases appeared to involve cytoplasmic protrusions of spindle-shaped macrophages. HIV-related Hodgkin lymphoma, therefore, is characterized by unique morphologic features, which should be recognized by pathologists.
In the era of combination antiretroviral therapy for HIV, incidences of AIDS-defining neoplasms like Kaposi sarcoma or non-Hodgkin lymphoma have markedly decreased. However, classical Hodgkin lymphoma is observed more frequently 1 and HIV patients have a 9.4-fold increased risk of developing classical Hodgkin lymphoma compared with the general population. 2, 3 Although HIV-related classical Hodgkin lymphoma occurs at any CD4 blood count, it is most frequently observed in patients with a moderate immune deficiency and CD4 blood counts of 150-249 cells/ml. 2, 4 As Hodgkin-and Reed-Sternberg cells, the tumor cells in classical Hodgkin lymphoma, usually constitute a small subpopulation of the cells in affected lymph nodes; it is likely that the microenvironment, largely composed of CD4 þ T regulatory 1 cells, has an essential role in the pathophysiology of the disease. 5 As HIV infection usually involves decreased CD4 þ T-cell counts in the peripheral blood, several studies have addressed the issue of the microenvironment in HIV-associated Hodgkin lymphoma and have found the CD4/CD8 T-cell ratio to be inverted. [6] [7] [8] [9] However, the number of cases examined was very small in the majority of the studies 6, 8, 9 (o10 HIV-positive classical Hodgkin lymphoma cases each). Thompson et al 7 analyzed 47 HIV-positive Hodgkin lymphoma cases and found a 'sarcomatoid' pattern of the reactive microenvironment to be significantly associated with an adverse clinical outcome.
In recent studies, an increased number of tumor-associated macrophages in classical Hodgkin lymphoma was strongly associated with shortened survival of the patients. [10] [11] [12] However, other studies could not confirm this finding. 13, 14 In the present study, we aimed to further characterize the morphologic and immunohistochemical characteristics of HIV-associated Hodgkin lymphoma in comparison to classical Hodgkin lymphoma in non-HIV infected individuals with respect to the composition of the microenvironment and the tumor cell content. The objective of this study was also to evaluate if HIV-associated Hodgkin lymphoma presents a particularly high content of macrophages and if this is related to a 'sarcomatoid' appearance of the infiltrate.
Materials and methods

Tissue Samples
All Hodgkin lymphoma cases with known HIV-1 infection of the patients diagnosed between 1986 and 2012 at the Senckenberg Institute of Pathology (n ¼ 54) were included in the study. Of the original 54 patients, paraffin blocks with representative Hodgkin infiltrates could be retrieved in 25 patients (24 lymph nodes, 1 bone marrow). As a control group, lymph nodes from 15 non-HIV infected patients with classical Hodgkin lymphoma (EBVassociated mixed cellularity type) were selected. All cases were reviewed by histologic analysis applying a basic immune marker panel (CD30, CD15, PAX5, LMP1, CD20, CD3), and diagnoses were confirmed in all cases. 15 cases of nonspecific lymphadenitis were additionally stained for CD8. Informed consent was obtained in accordance with the Declaration of Helsinki, and approval of the ethics committee of the University Hospital of Frankfurt was obtained (No. 254/12).
Immunohistochemistry, Quantification and Statistics
Immunohistochemical stainings (CD4, CD8, CD163, CD30 and S100) were performed using the Alkaline Phosphatase-Real Detection Kit (DAKO, Glostrup, Denmark) as described previously. 15 The antibodies used, dilutions and providers are listed in Supplementary Table 1. Antigen unmasking was performed for 2 min in a pressure cooker in TRIS-EDTA at pH 8.0. Immunohistochemical stainings were quantified using a light microscope equipped with a camera system (Microdissection Axiovert 200 M microscope, PALM, Bernried, Germany). For each slide, three representative counting frames (12 2824 mm 2 ) were chosen, and the number of positively stained cells was point-counted using PALM software. All lymph node biopsies were also assessed for morphologic features including the presence of germinal centers (GC), epithelioid cell clusters, necrosis, a 'sarcomatoid' pattern and hyalinization in HE-staining. T-cell rosetting was evaluated by CD4-immunostaining and macrophage rosetting by CD163-immunostaining. Cell counting and assessment of histological parameters were carried out in each case without knowledge of the clinical parameters. The data were tested for the presence of a Gaussian distribution (Shapiro-Wilk test). If present, groups were compared using the unpaired t-test; otherwise, the Mann-Whitney test was applied.
Cocultures
CD4 þ T-cells and CD14 þ monocytes were isolated from peripheral blood of two healthy donors by magnetic cell separation (magnetic-activated cell sorting) with CD4-and CD14-microbeads (Miltenyi Biotec, Cologne, Germany). Isolation of monocytes was performed prior to CD4 þ T-cell isolation to avoid contamination of the CD4 þ T-cell fraction with CD4 þ monocytes. High purity of the magnetic cell separation was confirmed by FACS analysis. The classical Hodgkin lymphoma cell lines KM-H2, L-428 and L-1236 as well as the Burkitt cell line Ramos were cocultured with CD4 þ T-cells, monocytes or a 1:1 mixture of both for 5 days. The ratio of cell line to primary cells was 1:20. Cocultures were set up in triplicate. As negative controls, CD4 þ T-cells, monocytes and the cell lines were cultured alone. Cultures were assessed under a Nikon ECLIPSE TE 300 microscope and sizes of cell clusters were evaluated using ImageJ 1.46 software (http://rsbweb.nih.gov/ij/). Smears obtained from the cultures were immunostained for CD4 and CD14.
Results
Clinicopathologic Features
The mean patient age of the HIV-positive Hodgkin lymphoma cohort was 47 years (range 28-73 years). Twenty patients were male and five patients were female. Clinical data were available for 15 classical Hodgkin lymphoma patients: Three patients presented with stage IIA/B, three patients with stage IIIB and nine cases with stage IVA/B; 10 patients had received combination antiretroviral therapy prior to therapy and five patients had not received previous antiviral therapy. CD4 þ T-cell counts at diagnosis of Hodgkin lymphoma were 27-526/ml (mean 152/ml). The Hodgkin lymphoma subtypes were mixed cellularity in 19 cases, not otherwise specified in three cases, nodular sclerosis in two cases, and lymphocyte-depleted in one case. In all cases, the Hodgkin-and Reed-Sternberg cells were positive for the EBV-coded latent membrane protein 1. The mean patient age of the control group (HIV-negative classical Hodgkin lymphoma) was 39 years (range 6-76 years). All cases in the control group were classified as EBV-positive mixed cellularity.
Histological and Immunohistochemical Findings
The most striking differences observed between HIV-associated Hodgkin lymphoma and HIVnegative classical Hodgkin lymphoma were the presence of small to large confluent necrotic foci (11 of 23 cases) and the absence of CD163-negative epithelioid cell clusters (0 of 23 cases) in HIVassociated classical Hodgkin lymphoma (Table 1, Figure 1 ). In the control group of HIV-negative classical Hodgkin lymphoma, all of which were of mixed cellularity, necrosis was never observed, whereas 9 of 15 cases presented epithelioid cell clusters. A 'sarcomatoid' pattern 7 was more frequently observed in HIV-associated Hodgkin lymphoma cases than in HIV-negative Hodgkin lymphoma (13/23 vs 4/15 cases), but was not specific for HIV-associated disease. Large hyalinized areas of the lymph node were observed in 8 HIV-related Hodgkin lymphoma cases, whereas such areas were present in only one HIV-negative case. Residual germinal centers were rarely observed either in HIV-associated Hodgkin lymphoma or HIV-negative Hodgkin lymphoma (2 of 24 cases and 5 of 15 cases, respectively).
Composition of the Microenvironment
As expected, CD4 numbers were significantly lower in HIV-related Hodgkin lymphoma than in the HIVnegative cases (876 vs 3465 cells/mm 2 , Po0.001, unpaired t-test, Figure 2 ). CD8 numbers were stable between the two groups (2699 vs 2835 cells/mm 2 ) and were comparable with CD8 numbers in nonspecific lymphadenitis (2947 cells/mm 2 ). The number of CD163 þ macrophages was significantly increased in HIV-associated Hodgkin lymphoma compared with HIV-negative Hodgkin cases (2836 vs 1430 cells/mm 2 , P ¼ 0.0025, unpaired t-test, Figure 2 ). The number of S100 þ dendritic cells and Hodgkin-and Reed-Sternberg cells did not differ between HIV-related Hodgkin lymphoma and HIV-negative Hodgkin lymphoma cases (284 vs 331 and 267 vs 285 cells/mm 2 ).
Among the HIV-associated Hodgkin lymphoma cases for which clinical data were available, we also determined if the number of CD163 þ macrophages and CD4 þ T-cells in the lymph node was dependent on previous combination antiretroviral therapy, the virus load or the CD4 blood count at diagnosis. There was no difference in the number of CD163 þ macrophages between the groups with and without combination antiretroviral therapy (2943 vs 2905 cells/mm 2 ). The difference in CD4 þ T-cells in the HIV-associated Hodgkin lymphoma microenvironment between the group receiving (n ¼ 10) and not receiving combination antiretroviral therapy (n ¼ 6) was not significant (1327 vs 554 cells/mm 2 ). Neither were the differences in the number of CD4 þ T-cells or macrophages significant between cases with a high (Z340 copies/ml, n ¼ 7) or a low virus load (o20 copies/ml, n ¼ 5, 698 vs 2238 CD4 þ cells/mm 2 and 3753 vs 2028 CD163 cells/mm 2 ). However, three of the HIV-associated Hodgkin lymphoma cases had a CD4 blood count 4250/ml at diagnosis, and these cases also showed significantly higher CD4 þ T-cell numbers and lower macrophage counts in the tissue than the other cases with CD4 blood counts o250/ml (n ¼ 11; 3756 vs 465 CD4 þ cells/mm 2 , P ¼ 0.0127 and 1389 vs 3458 CD163 cells/mm 2 , P ¼ 0.0293, both MannWhitney test). As necrosis was an important feature in HIV-associated Hodgkin lymphoma, we also investigated if there was a relationship between the presence of necrosis and the numbers of CD4 þ T-cells, CD8 þ T-cells or CD163 þ macrophages. There was a significantly higher number of CD163 þ macrophages in the HIV-related Hodgkin lymphoma cases with necrosis (n ¼ 11; 3248 cells/mm 2 ) compared with HIV-related Hodgkin lymphoma Figure 2 ). The differences in the numbers of CD4 þ T-cells and CD8 þ T-cells were not significant (376 vs 1357 CD4 þ cells/mm 2 and 2273 vs 3065 CD8 þ cells/mm 2 ). We also wanted to determine if the 'sarcomatoid' appearance observed in some cases was related to a high macrophage content. As a 'sarcomatoid' pattern was not specific for the HIV-associated Hodgkin lymphoma group and was also found in 4 HIVnegative classical Hodgkin lymphoma cases, we grouped all 'sarcomatoid' cases for the analysis. Modern Pathology (2013) 26, 648-657
Macrophages in HIV-related Hodgkin lymphoma
This revealed that the number of CD163 þ macrophages was significantly higher in all cases with a 'sarcomatoid' pattern (2681 vs 1767 cells/mm 2 , P ¼ 0.027, unpaired t-test).
Rosetting around Hodgkin-and Reed-Sternberg Cells
As 
Discussion
In the present study, we compared 24 HIVassociated Hodgkin lymphoma cases with 15 HIV-negative classical Hodgkin lymphoma cases. We confirmed previous findings of a severely altered microenvironment in HIV-associated Hodgkin lymphoma with decreased CD4 numbers in the tissue. [6] [7] [8] [9] Although previous studies observed an inverted CD4/CD8 T-cell ratio, we showed that this is merely due to decreased CD4 numbers, whereas the absolute number of CD8 þ T-cells was stable in HIV-positive and HIV-negative cases. Interestingly, this study showed significantly increased numbers of CD163 þ macrophages in HIV-related Hodgkin lymphoma, whereas the numbers of S100 þ dendritic cells and Hodgkin-and Reed-Sternberg cells were similar between HIV-positive and HIV-negative cases. This is surprising, as one could suspect that HIV-associated Hodgkin lymphoma cases would present a higher content of Hodgkin-and Reed-Sternberg cells due to impaired surveillance by the immune system. A high number of macrophages has been correlated with frequent treatment failure in classical Hodgkin lymphoma. [10] [11] [12] As the cases in the present series were collected over a long period of time, treatment protocols were heterogeneous and clinical data were not available in all cases. Therefore, the prognostic impact of macrophages in HIV-associated Hodgkin lymphoma should be assessed in future studies.
In a clinical study of a large cohort of HIVpatients, it was shown that patients with and without combination antiretroviral therapy experienced a decrease in CD4 þ T-cell counts in the peripheral blood in the year preceding the diagnosis of classical Hodgkin lymphoma. 4 This observation was possible because CD4 þ T-cell blood counts in HIV-patients are usually well documented. It can be expected that HIV-negative individuals will react in the same manner, although this has not been documented. In our view, CD4 þ T-cells are likely to be recruited from the peripheral blood to lymph nodes infiltrated by classical Hodgkin lymphoma via cytokines such as TARC and RANTES/CCL5 secreted by the Hodgkin-and Reed-Sternberg cells. 16 Interestingly, although only CD4 þ T-cells express CCR4, 17 both CD4 þ T-cells and macrophages express CD4 and CCR5. Although HIV-infected CD4 þ T-cells are eliminated in high numbers, macrophages usually persist as viral reservoirs. 18 As CCR5 not only represents the HIV fusion coreceptor, but also the ligand for RANTES, macrophages become increasingly attracted to the affected lymph nodes in the absence of CD4 þ T-cells. Thus, in more severely immunocompromised HIV-patients with low CD4 blood counts, monocytes/macrophages may take over the role of CD4 þ T-cells. We also found in cell culture experiments that monocytes are equally good at forming clusters and rosettes with Hodgkin cell lines, in line with a previous study. 19 Macrophage rosetting is, therefore, likely to occur in the absence of CD4 þ T-cells, but is not hampered by the presence of T-cells.
Thompson et al 7 found a 'sarcomatoid' pattern of the reactive microenvironment associated with a worse clinical outcome in HIV-related Hodgkin lymphoma. In the present study, we also observed the 'sarcomatoid' pattern more frequently in HIVrelated Hodgkin lymphoma than in HIV-negative classical Hodgkin lymphoma. However, this was not a specific finding in HIV patients. We associated the 'sarcomatoid' pattern with a spindle-shaped appearance of the macrophages in the microenvironment and found also a significantly higher content of macrophages in cases with the 'sarcomatoid' pattern. As epithelioid cell clusters were virtually absent in all cases with a 'sarcomatoid' pattern, the spindle-shaped appearance of macrophages in this pattern may reflect a functional differentiation state distinct from the epithelioid cell state and indicative of poor prognosis. Previous studies have suggested that CD4 þ T-cells are required for epithelioid cell formation. [20] [21] [22] Macrophage activation is a multistep process and has been divided into proinflammatory/ M1 or regulatory/M2 polarization. 23, 24 Although epithelioid cell formation in sarcoidosis and tuberculosis was shown to be associated with an M1 phenotype of macrophages, 25, 26 tumor-associated macrophages were usually found to have an M2-like phenotype. 24, 27 Data on macrophage polarization in HIV are contradictory, and a switch from M1 to M2 polarization of macrophages during the disease course has been proposed. 28 Whereas HIV-infection of macrophages was shown to induce an M1-like phenotype with a hypersensitivity to Toll-like receptor agonists shortly after the infection, 29 the fraction of CD163 þ and CD16 þ double-positive monocytes, which are precursors of alternatively activated macrophages, were increased in HIV-patients with low CD4 þ T-cell blood counts, 30 as was soluble CD163 in serum. 31 CD163, usually known as a typical M2 marker and strongly expressed in the spindle-shaped macrophages of HIV-related Hodgkin lymphoma, was recently found to be expressed on a subset of M1-polarized macrophages. 32 The presence of necrotic foci, a unique feature in the HIV-related Hodgkin lymphoma cases in the present study, may point to a proinflammatory activity. Cassol et al 33 observed a significant increase in spindle-shaped cells after differentiation of monocytes into M1 compared with M2a differentiated macrophages. Interestingly, one patient of the four HIV-negative Hodgkin lymphoma cases with a 'sarcomatoid' pattern was suffering from chronic hepatitis C virus (HCV) infection and another patient had a severe concurrent infection resulting in a CD4 þ T-cell blood count o500/ml, as frequently observed in sepsis. 34 HCV, cytomegalovirus and influenza virus have also been shown to induce an M1 phenotype in macrophages. 35, 36 Thus, other conditions concomitant with classical Hodgkin lymphoma can induce changes resembling the spindle cell macrophages observed in HIV-associated Hodgkin lymphoma. The spindle shape appearance of macrophages in HIV-associated Hodgkin lymphoma may be an abortive attempt of epithelioid cell formation in the absence of CD4 þ T-cells.
All cases available in our registry were EBVpositive, in line with previous studies. 37, 38 Thus, the clonal expansion of Hodgkin-and Reed-Sternberg cells in HIV-associated Hodgkin lymphoma probably shares several features of transformation with EBV-infected Hodgkin-and Reed-Sternberg cells arising in different conditions of immunosuppression like peripheral T-cell lymphomas, 39 B-chronic lymphocytic leukemia, 40, 41 or EBVpositive diffuse large B-cell lymphoma of the elderly. 42 In concert with the particular composition of the microenvironment, we propose that HIV-related Hodgkin lymphoma associated with a high content of spindle-shaped macrophages and low CD4 þ T-cell content represents a unique subtype of classical Hodgkin lymphoma, which should be recognized by pathologists.
